{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:19:49Z","timestamp":1782512389032,"version":"3.54.5"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HDTRA 1-12-D-0003-0019"],"award-info":[{"award-number":["HDTRA 1-12-D-0003-0019"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,5,18]]},"abstract":"<jats:p>\n            Infection with aerosolized\n            <jats:named-content content-type=\"genus-species\">Francisella tularensis<\/jats:named-content>\n            or\n            <jats:named-content content-type=\"genus-species\">Yersinia pestis<\/jats:named-content>\n            can lead to lethal disease in humans if treatment is not initiated promptly. Finafloxacin is a novel fluoroquinolone which has demonstrated broad-spectrum activity against a range of bacterial species\n            <jats:italic>in vitro, in vivo<\/jats:italic>\n            , and in humans, activity which is superior in acidic, infection-relevant conditions.\n          <\/jats:p>","DOI":"10.1128\/aac.02294-20","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T13:46:22Z","timestamp":1616507182000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection"],"prefix":"10.1128","volume":"65","author":[{"given":"Kay B.","family":"Barnes","sequence":"first","affiliation":[{"name":"Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"Richards","sequence":"additional","affiliation":[{"name":"Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Laws","sequence":"additional","affiliation":[{"name":"Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Animal and Plant Health Agency, Surrey, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne E.","family":"Thwaite","sequence":"additional","affiliation":[{"name":"Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bentley","sequence":"additional","affiliation":[{"name":"MerLion Pharmaceuticals, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0159-5117","authenticated-orcid":true,"given":"Sarah V.","family":"Harding","sequence":"additional","affiliation":[{"name":"Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2068"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12706"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a010314"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1112551"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.6.2.231"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00115"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-019-0065-0"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bsheal.2019.09.001"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30730-8"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0105-9"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000309"},{"key":"e_1_3_3_13_2","first-page":"61","article-title":"Tularemia pneumonia","volume":"12","author":"Gill V","year":"1997","unstructured":"Gill V, Cunha BA. 1997. Tularemia pneumonia. Semin Respir Infect 12:61\u201367.","journal-title":"Semin Respir Infect"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2014.00040"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00306-06"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2763"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/313946"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/322601"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1994.51.109"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/21.3.650"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2014.00036"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.17.2281"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01519-17"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2303.161212"},{"key":"e_1_3_3_25_2","volume-title":"USAMRIID\u2019s medical management of biological casualties handbook","author":"Withers MR","year":"2014","unstructured":"Withers MR. 2014. USAMRIID\u2019s medical management of biological casualties handbook, 8th ed. U.S. Army Medical Research Institute of Infectious Disease, Fort Detrick, MD.","edition":"8"},{"key":"e_1_3_3_26_2","first-page":"455","article-title":"Quinolones: a comprehensive review","volume":"65","author":"Oliphant CM","year":"2002","unstructured":"Oliphant CM, Green GM. 2002. Quinolones: a comprehensive review. Am Fam Physician 65:455\u2013464.","journal-title":"Am Fam Physician"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01637-09"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.03.002"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.5.1298"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.07.028"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0384-z"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02317-17"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02325-17"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01470-19"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00082-17"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00904"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01104-12"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im1914s93"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0882-4010(03)00046-9"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00091"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02420-14"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.11.7142-7150.2005"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2013.00106"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02504-12"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplegacy.1947.150.1.70"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1017\/s0022172400039504"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02294-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02294-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:27:20Z","timestamp":1645486040000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02294-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,5,18]]}},"alternative-id":["10.1128\/AAC.02294-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.02294-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"2020-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02294-20"}}